. .
.
. Mayo Clinic Health Solutions
.
. .
.
Search:
Browse Categories:
  arrow Research Tools
arrow
  arrow Diagnostics
arrow
  arrow Therapeutics
arrow
  arrow Medical Devices
arrow
  arrow Electronic Devices
arrow
  arrow Software
arrow
  arrow All Listings
arrow
arrow
  Home
arrow
  About Us
arrow
  Contact Us
arrow
arrow
  Go to mayoclinic.org
arrow
  Go to Research at Mayo Clinic
arrow
Mayo Clinic Technology
.

Human Glutathione S-transferase Omega 2 (GSTO2) Genetic Polymorphisms

Reference #:

2004-273

Inventors/Contributors

Richard M. Weinshilboum, M.D., Oreste Ezequiel Salavaggione, M.D., Baidehi (Luna) Mukherjee, Linda L. Pelleymounter, Eric D. Wieben, Ph.D.

Description

GST02 is a phase II enzyme that utilize glutathione in reactions contributing to the transformation of a wide range of exogenous and endogenous compounds, including carcinogens, therapeutic drugs, and products of oxidative stress. Known substrates are glutathione (GSH) and dehydroascorbate (DHA. It is expressed in liver, kidney and skeletal muscle and at high levels in the testes and low levels in the heart, lung, cervix, ovary and prostate. Three novel non-synonymous cSNPs have been identified and their functional relevancy is being determined. Novel polymorphisms and common haplotypes for Caucasian American, African American, Han Chinese and Mexican American populations have been identified.

Patent Status

button

U.S. Patent Number 7,390,894
Issued June 24, 2008

Contact

Leif R. Nelson, Licensing Manager
nelson.leif@mayo.edu

Mayo Foundation for Medical Education and Research
Office of Technology Commercialization
Centerplace 4
200 First Street SW
Rochester, MN 55905

Phone: (507) 266-0820
Fax: (507) 284-5410